Radiation Oncology Market: By Technolgy, Brachytherapy, & Systemic Radiotherapy, Product, & By Application & By Region - Forecast 2016-2021 - Product Image

Radiation Oncology Market: By Technolgy, Brachytherapy, & Systemic Radiotherapy, Product, & By Application & By Region - Forecast 2016-2021

  • ID: 3974189
  • Report
  • 165 pages
  • IndustryARC
1 of 3
Radiation oncology or radiation therapy is therapy to stop cancer cells from multiplying and cancer to spread and result into fatality. Radiation oncology uses ionizing radiation to control or kill malignant cancer cells and cure the disease permanently. According to the WHO, the number of new patients of cancer is expected to grow by 70% in the next two decades. The growing number of cancer patients around the world is the chief driving force behind the global radiation oncology market’s growth however higher cost and adequate infrastructure in the major parts of the world is expected to be key restraining factor for the global radiation oncology market.

Geographically North America dominated radiation oncology market driven by best in the class healthcare infrastructure, advanced facilities, higher awareness, higher technological penetration and higher spending by the citizens towards healthcare expenditure. North America was followed by Europe and Asia-Pacific as second and third largest market for radiation oncology market. Asia Pacific is projected to have fastest growth, owing to rapidly increasing healthcare infrastructure, increased spending, government initiatives and increasing awareness amongst population, and growing medical tourism industry in developing nations such as China, and India in this region.

This report identifies the global radiation oncology market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to global radiation oncology market.

This report segments global radiation oncology market on the basis of application, test type and regional market as follows:
Radiation Oncology Market, By Application: External Beam Radiation Therapy (Prostate Cancer, Breast Cancer, Lung Cancer, Head & Neck Cancer, Colorectal Cancer and Other), Internal Radiation Therapy (Prostate Cancer, Gynecological Cancer, Breast Cancer, Cervical Cancer, Penile Cancer and Other)

Radiation Oncology Market, By Technology: External Beam Radiation Therapy (Image-Guided Radiotherapy (IGRT), Intensity Modulated Radiotherapy (IMRT), Stereotactic Technology, Proton Beam Therapy, Tomotherapy, 3D Conformal Radiotherapy (3D CRT), Volumetric Modulated Arc Therapy (VMAT) ), Internal Beam Radiotherapy (Low Dose Rate, High Dose Rate), Systemic Radiation Therapy

Radiation Oncology Market, By Product: External beam radiation therapy (Compact Advanced Radiotherapy Systems, Proton Therapy Systems, Electron Emitting High Energy Linear Accelerators (Linac)), Internal Radiation Therapy/Brachytherapy, Systemic Radiation Therapy
This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region
This report identifies all the major companies operating in the radiation oncology market. Some of the major companies’ profiles in detail are as follows:
C. R. Bard, Inc.

Isoray Medical, Inc.

Raysearch Laboratories AB
Mevion Medical Systems, Inc.
Mitsubishi Electric Corporation
Please Note: The report is to be delivered in 1-2 working days after an order is placed.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. Radiation Oncology Market – Market Overview

2. Executive Summary

3. Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.3. Product Benchmarking
3.4. End User Profiling
3.5. Top 5 Financials Analysis

4. Radiation Oncology Market– Market Forces
4.1. Drivers
4.1.1. Technological Advancement
4.1.2. Growing Number of Cancer Patients
4.2. Restraints
4.2.1. Lack of Adequate Infrastructure & Healthcare Expenditure
4.3. Opportunities
4.3.1. Emerging Markets Offer Numerous Growth Opportunities
4.4. Challenges
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Degree of Competition

5. Radiation Oncology Market– Strategic Analysis
5.1. Value Chain Analysis
5.2. Pricing Analysis
5.3. Opportunities Analysis
5.4. Product/Market Life Cycle Analysis
5.5. Suppliers and Distributors

6. Radiation Oncology Market, By Product
6.1. External beam radiation therapy
6.1.1. Compact Advanced Radiotherapy Systems
6.1.1.1. Cyberknife
6.1.1.2. Gamma Knife
6.1.1.3. Tomotherapy
6.1.2. Proton Therapy Systems
6.1.2.1. Cyclotron
6.1.2.2. Synchrotron
6.1.3. Electron Emitting High Energy Linear Accelerators (Linac)
6.2. Internal Radiation Therapy/Brachytherapy
6.2.1. Seeds
6.2.2. Applicators & Afterloaders
6.2.3. Electronic Brachytherapy
6.3. Systemic Radiation Therapy

7. Radiation Oncology Market, By Technolgy
7.1. External Beam Radiation Therapy
7.1.1. Image-Guided Radiotherapy (IGRT)
7.1.2. Intensity Modulated Radiotherapy (IMRT)
7.1.3. Stereotactic Technology
7.1.4. Proton Beam Therapy
7.1.5. Tomotherapy
7.1.6. 3D Conformal Radiotherapy (3D CRT)
7.1.7. Volumetric Modulated Arc Therapy (VMAT)
7.2. Internal Beam Radiotherapy
7.2.1. Low Dose Rate
7.2.2. High Dose Rate
7.3. Systemic Radiation Therapy

8. Radiation Oncology Market, By Application
8.1. External Beam Radiation Therapy
8.1.1. Prostate Cancer
8.1.2. Breast Cancer
8.1.3. Lung Cancer
8.1.4. Head & Neck Cancer
8.1.5. Colorectal Cancer
8.1.6. Other
8.2. Internal Radiation Therapy
8.2.1. Prostate Cancer
8.2.2. Gynecological Cancer
8.2.3. Breast Cancer
8.2.4. Cervical Cancer
8.2.5. Penile Cancer
8.2.6. Other

9. Radiation Oncology Market, By Geography
9.1. Europe
9.1.1. Germany
9.1.2. France
9.1.3. Italy
9.1.4. Spain
9.1.5. Russia
9.1.6. U.K.
9.1.7. Rest of Europe
9.2. Asia Pacific
9.2.1. China
9.2.2. India
9.2.3. Japan
9.2.4. South Korea
9.2.5. Rest of Asia-Pacific
9.3. North America
9.3.1. U.S.
9.3.2. Canada
9.3.3. Mexico
9.4. Rest of the World (RoW)
9.4.1. Brazil
9.4.2. Rest of RoW

10. Radiation Oncology – Market Entropy
10.1. Expansion
10.2. Technological Developments
10.3. Merger & Acquisitions, and Joint Ventures
10.4. Supply- Contract

11. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
11.1. Varian Medical Systems, Inc.
11.2. Elekta AB
11.3. Accuray Incorporated
11.4. IBA (Ion Beam Applications Sa)
11.5. Nordion, Inc.
11.6. C. R. Bard, Inc.
11.7. Isoray Medical, Inc.
11.8. Raysearch Laboratories AB
11.9. Mevion Medical Systems, Inc.
11.10. Mitsubishi Electric Corporation
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"

12. Appendix
12.1. Abbreviations
12.2. Sources
12.3. Research Methodology
12.4. Bibliography
12.5. Compilation of Expert Insights
12.6. Disclaimer
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll